At some point in collaborations formal arrangements – in whatever form – will become relevant. Please involve IXA at the earliest stage possible to assist you with this. The IXA legal counsels have extensive experience in drafting and negotiating contracts. Do you have a request from industry regarding the use of your research results? At IXA we are committed to negotiating a fair deal.
In many cases, the COVID-19 crisis has an impact on current research contracts with cooperation partners and grant providers. For more information about force majeure due to COVID-19 please look at this page.
Please do not hesitate to contact our legal department if you need advice in matters such as:
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News